Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease
BACKGROUND: In Switzerland, the first course of intravenous steroids for treatment of episodes of demyelinating CNS disease is usually administered in an inpatient setting. We prospectively evaluated short term tolerance of treatment with special emphasis on sleep quality. METHODS:...
Main Authors: | Carmen Lienert, Gabriela Schawalder, Oliver Findling, Christian P Kamm, Sebastian Humpert, Anne Mugglin, Johannes Mathis, Mathias Sturzenegger, Heinrich P Mattle |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2013-05-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1689 |
Similar Items
-
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
by: Steffen Pfeuffer, et al.
Published: (2022-09-01) -
Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy
by: Kenneth K. H. Lai, et al.
Published: (2023-05-01) -
Role of oral corticosteroids with adjunct to intravenous antibiotics in treatment of orbital cellulitis
by: Sangeeta Shah, et al.
Published: (2022-12-01) -
Intravenous Immunoglobulin Responsive Persistent Thrombocytopenia after Dengue Haemorrhagic Fever
by: Prabhat Kumar, et al.
Published: (2016-04-01) -
Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
by: Joanna Rymuza, et al.
Published: (2022-08-01)